Cigna Investments’s Weis Markets WMK Stock Holding History

Cigna Investments’s Portfolio WMK Stock Details WMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,626	Closed	-$628K	–	770
2018 Q3	$628K	Buy	+13,626	New	+$662K	0.05%	291
2018 Q2	–	Sell	-9,401	Closed	-$385K	–	811
2018 Q1	$385K	Sell	9,401 -2,138	-19%	-$84K	0.03%	555
2017 Q4	$478K	Hold	11,539	–	–	0.03%	501
2017 Q3	$502K	Buy	+11,539	New	+$524K	0.03%	457

Other funds holding WMK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cigna Investments's WMK Position: Q4 2018 in Review

Cigna Investments sold out of Weis Markets (WMK) in Q4 2018, closing a stake of 13,626 shares — an estimated $628K sold.

Cigna Investments first reported a position in WMK in Q3 2017 and held it in 4 quarters. The position peaked at $628K in Q3 2018. 123 funds tracked by Wall St. Rank hold WMK as of Q4 2018.

Cigna Investments reported no remaining Weis Markets position as of Q4 2018 after selling out during the quarter.
Cigna Investments sold 13,626 Weis Markets shares in Q4 2018, an estimated $628K.
Cigna Investments first reported a position in Weis Markets in Q3 2017 and held it in 4 quarters.
Cigna Investments's Weis Markets position peaked at $628K in Q3 2018.
123 funds tracked by Wall St. Rank held Weis Markets as of Q4 2018.

Based on Cigna Investments's 13F filing for Q4 2018, filed 6 Feb 2019.